ロード中...
Bevacizumab Monotherapy as Salvage Therapy for Advanced clear cell Renal Cell Carcinoma (ccRCC) Pretreated with Targeted Drugs
Bevacizumab has shown benefit in the first line setting in combination with interferon; however, data on use as monotherapy are limited. This retrospective analysis of 71 patients assesses the efficacy of bevacizumab monotherapy in patients who progressed on other targeted drugs. Bevacizumab monothe...
保存先:
| 出版年: | Clin Genitourin Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4965701/ https://ncbi.nlm.nih.gov/pubmed/26404107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2015.07.010 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|